Syntax Research »

C4 Therapeutics shares owned by Syntax Research

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Syntax Research from 13F filings

Historical chart of Syntax Research investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Syntax Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Syntax Research

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.7k 1.0k 5.65

More positions owned by Syntax Research

Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Msci Usa Value (VLUE)
Apple (AAPL)
Ishares Tr Core S&p Mcp Etf (IJH)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Msci Acwi Ex Us (ACWX)
Proshares Tr S&p 500 Dv Arist (NOBL)
Ishares Tr Core Msci Euro (IEUR)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Qualcomm (QCOM)
Microsoft Corporation (MSFT)
FedEx Corporation (FDX)
American Tower Reit (AMT)
Prologis (PLD)

View all positions for Syntax Research

Top funds holding C4 Therapeutics

RA Capital Management
Daniel D. Thurber
Commodore Capital
Lynx1 Capital Management
T. Rowe Price Associates
Arrowpoint Asset Management
Vanguard Group
Point72 Asset Management
Soleus Capital Management
Balyasny Asset Management
Bank of America Corporation
Marshall Wace
Millennium Management
Citadel Advisors
Cubist Systematic Strategies

View all funds holding C4 Therapeutics